SEC Form 4Coverage since May 13, 2026
$GDTC insider trading
Over the last 12 months, CytoMed Therapeutics insiders reported 2 buys totaling $429K and no sales across SEC Form 4 filings.
- Bought · 12m
- $429K 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $GDTC · 12Mvia TradingView
Top insiders · 12m
Choo Chee Kong—2× · $429K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Choo Chee KongD·10% | ▲ Buy | 200,000 | $1.5 | $300K | +46.5% | late · 2 tranches |
| May 13, 2026 | Choo Chee KongD·10% | ▲ Buy | 112,000 | $1.15 | $129K | +35.2% | late |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GDTC feed.